Nav: Home

Effects of MVA85A vaccine on tuberculosis

September 09, 2015

Liverpool, 9 September 2015 - A new systematic review of animal studies testing a vaccine for tuberculosis raises questions about whether the studies provided sufficient evidence to move into trials of children.

The new vaccine was a virus-expressing antigen 85A (MVA85A) designed to boost the immunity offered by the existing Bacillus Calmette-Guérin (BCG) vaccine which has little protective effect in practice. The review, published today in the International Journal Epidemiology, evaluates the animal evidence that contributed to the decision to conduct human studies.

LSTM's Professor Paul Garner is the senior author on the review, and coordinating editor at the Cochrane Infectious Diseases Group. Working along with colleagues at the University of Edinburgh and South Africa, the team included data from studies where animals were given the MVA85A booster with BCG and then exposed to a TB challenge, and compared their outcome with that in animals receiving BCG alone. The team identified eight studies published up to September 2014, involving a total of 192 animals.

Different kinds of animals were used in the different studies, but overall the authors found that studies were too small, the quality was low, and details of the experimental methods used were poorly reported. Combining the findings from all studies gave no evidence to support the effectiveness of MVA85A as a BCG booster.

What surprised the review authors was the delay with publishing the largest monkey trial with the longest follow up. This trial had 5 deaths out of 6 monkeys in the new vaccine group compared to two deaths in the 6 monkeys in the control group who only got BCG. This trial only appeared in the public domain after the researchers had received funding for an experimental human trial and had recruited over half of the 2797 infants in South Africa needed.

"This is very disappointing", said Professor Garner. "Tuberculosis remains a major health challenge in many parts of the world and - as with every field of research - we all have a responsibility to work to the highest standards of scientific integrity. We need to make our findings accessible to as wide an audience as quickly as possible. You don't bury results you don't like. It can mislead other scientists, and misinforms the public".
-end-
Note to editors:

1) In the UK researchers can only use animals in trials where there are no alternative methods available and are required, by law, to use the minimum number necessary to achieve results. A robust study design is vital for ensuring the maximum amount of valid information is gained from those animals used.

2) Systematic reviews are the best way of summarising knowledge from existing research. By combining all available information in one place they are much more powerful than any single study can be, and by scrutinising the research methods used they can highlight weaknesses in the available evidence.

3) The Cochrane Infectious Diseases Group was established in 1995 to prepare and update scientifically defensible systematic reviews of reliable research about the effects of health care to help inform policy, practice and research. The Group receives funding from the Department for International Development.

4) The CAMARADES group was established in 2005 to conduct systematic reviews of data from animal experiments, and receives funding from the UK NC3Rs to support its work.

For further information, please contact:

Mrs Clare Bebb
Senior Media Officer
Liverpool School of Tropical Medicine
Office: +44 (0)151 705 3135
Mobile: +44 (0)7889535222
Email: clare.bebb@lstmed.ac.uk

Liverpool School of Tropical Medicine (LSTM) has been engaged in the fight against infectious, debilitating and disabling diseases since 1898 and continues that tradition today with a research portfolio in excess of well over £200 million and a teaching programme attracting students from over 65 countries.

For further information, please visit: http://www.lstmed.ac.uk

Liverpool School of Tropical Medicine

Related Vaccine Articles:

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.
US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.
Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.
Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.
Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.
Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.
Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.
On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.
Study examines first birth cohort to receive HPV vaccine: The vaccine works
Girls in the first birth cohort to be offered and receive the HPV vaccine showed a lower degree of dysplasia which may eventually lead to cervical cancer than a birth cohort from 1983.
False beliefs about MMR vaccine found to influence acceptance of Zika vaccine
People's willingness to use a Zika vaccine, once it's available, will be influenced by how they weigh the risks associated with the disease and the vaccine, but also by their misconceptions about other vaccines.
More Vaccine News and Vaccine Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#566 Is Your Gut Leaking?
This week we're busting the human gut wide open with Dr. Alessio Fasano from the Center for Celiac Research and Treatment at Massachusetts General Hospital. Join host Anika Hazra for our discussion separating fact from fiction on the controversial topic of leaky gut syndrome. We cover everything from what causes a leaky gut to interpreting the results of a gut microbiome test! Related links: Center for Celiac Research and Treatment website and their YouTube channel
Now Playing: Radiolab

The Flag and the Fury
How do you actually make change in the world? For 126 years, Mississippi has had the Confederate battle flag on their state flag, and they were the last state in the nation where that emblem remained "officially" flying.  A few days ago, that flag came down. A few days before that, it coming down would have seemed impossible. We dive into the story behind this de-flagging: a journey involving a clash of histories, designs, families, and even cheerleading. This show is a collaboration with OSM Audio. Kiese Laymon's memoir Heavy is here. And the Hospitality Flag webpage is here.